Skip to content

Clinical trials

Mental Disorders trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Country / region: Poland Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20112
20121
20142
20161
20171
20181
20201
20211
20224
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated5
Active, not recruiting3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.5
AstraZeneca3
H. Lundbeck A/S2
Alkahest, Inc.1
Eli Lilly and Company1
Emalex Biosciences Inc.1
Hoffmann-La Roche1
Inmune Bio, Inc.1
MapLight Therapeutics1
Neurocrine Biosciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders20
Brain Diseases9
Central Nervous System Diseases9
Nervous System Diseases9
Dementia8
Major Depressive Disorder8
Neurodegenerative Diseases8
Alzheimer Disease7
Neurocognitive Disorders7
Tauopathies7

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.